TuHURA BIOSCIENCES, INC./NV Current Liabilities
TuHURA BIOSCIENCES, INC./NV (HURA) had Current Liabilities of $9.26 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Liabilities, Current $9.26M.
- 2026-03-31: Liabilities, Current $6.07M.
- 2025-12-31: Liabilities, Current $5.92M.
- 2025-09-30: Liabilities, Current $8.83M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $9.26M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $6.07M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $5.92M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $8.83M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $15.17M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $4.78M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $5.33M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $2.26M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $2.26M 10-Q · filed 2024-11-14 | |
| 2024-03-31 | $1.34M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $3.60M 10-K · filed 2025-03-31 | $1.87M 10-Q · filed 2024-02-14 |
| 2023-09-30 | $3.34M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $3.08M 10-K · filed 2024-10-07 | |
| 2023-03-31 | $2.79M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $3.24M 10-Q · filed 2023-02-14 | |
| 2022-09-30 | $3.52M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $3.99M 10-K · filed 2023-09-18 | |
| 2022-03-31 | $3.24M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $3.44M 10-Q · filed 2022-02-11 | |
| 2021-09-30 | $3.00M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $2.78M 10-K · filed 2022-09-27 | |
| 2021-03-31 | $2.53M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $2.73M 10-Q · filed 2021-02-12 | |
| 2020-09-30 | $2.39M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $2.67M 10-K · filed 2021-09-28 | |
| 2019-06-30 | $2.07M 10-K · filed 2019-09-09 | |
| 2019-03-31 | $1.20M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $1.27M 10-Q · filed 2019-02-11 | |
| 2018-09-30 | $1.08M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $1.64M 10-K · filed 2019-09-09 | |
| 2018-03-31 | $2.01M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $2.23M 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $1.53M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $1.30M 8-K · filed 2019-06-03 | |
| 2017-03-31 | $1.02M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $721.01K 10-Q · filed 2017-02-10 | |
| 2016-09-30 | $482.27K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $627.45K 10-K · filed 2017-09-27 | |
| 2016-03-31 | $675.97K 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $535.84K 10-Q · filed 2016-02-12 | |
| 2015-09-30 | $411.54K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $853.09K 10-K · filed 2016-09-13 | |
| 2015-03-31 | $529.68K 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $294.19K 10-Q · filed 2015-02-12 | |
| 2014-09-30 | $335.66K 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $299.87K 10-K · filed 2015-11-16 | |
| 2014-03-31 | $440.21K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $249.49K 10-K · filed 2014-08-28 | |
| 2013-09-30 | $427.76K 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $667.69K 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $874.95K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $1.13M 10-K · filed 2014-08-28 | |
| 2012-03-31 | $9.98K 10-Q/A · filed 2012-06-05 | |
| 2011-06-30 | $0.00 10-Q/A · filed 2012-06-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |